IL17A and diabetes mellitus: Further, A1C levels were significantly higher in both untreated and anti-IL17A-treated diabetic mice than their non-diabetic controls 6 weeks after diabetes was confirmed (and 1 week after the anti-IL-17A intravitreal injection).